The binx io platform is an FDA-cleared and CLIA-waived molecular point-of-care system designed for the rapid detection of Chlamydia and Gonorrhea, providing laboratory-quality results in approximately 30 minutes. Utilizing PCR technology with electrochemical detection, this desktop system enables "test-and-treat" models in various clinical settings, significantly reducing the time from diagnosis to treatment. For more details on the platform, visit mybinxhealth.com . binx health io CT/NG Assay - U.S. Pharmacist